Winway Health Desk
Whistleblowers charge CEO of NJ firm with inflating AI capability, calling...
Edward Scott took over as CEO of ElectrifAi in late 2018.
For years, Opera Solutions did business as a data analytics consulting company helping clients...
DoD taps Google Cloud for digital pathology pilot
The Department of Defense is launching a digital pathology pilot program that would use AI combined with augmented reality microscopes to help with cancer...
Energizing Smoothie Bowl Recipe Packed With Veggies
While I love creating a variety of smoothie bowl recipes, I also think it is important to find a balance between sweet fruits and...
Survey: Covid-19 exacerbates mental health challenges
The stress of long lockdowns, job losses and other worries due to the Covid-19 pandemic is taking its toll on Americans. According to the...
Australian CDMO Luina Bio plots biologics manufacturing upgrades big and small
Australian contract research and manufacturing organization Luina Bio is teeing up multiple projects to grow its biologics capacity. Five new site expansions are expected to open by...
With new AveXis name, Novartis spotlights marquee role for gene therapy...
Call it a two for one: By changing the name of its AveXis unit to Novartis Gene Therapies, the Swiss drugmaker highlights the importance of...
A COVID-19 vaccine in early November? ‘Extremely unlikely, but not impossible’:...
With COVID-19 vaccine hype intensifying each day—including this week, with new comments from Pfizer’s CEO—the head of the U.S. government’s research program said it's "extremely unlikely" a...
Akebia crashes on vadadustat flop in larger anemia indication. Will AZ,...
What was previously expected to be a three-way battle in the novel HIF-PHI renal anemia drug class now has one man down. Akebia Therapeutics has...
Telemedicine and addiction recovery: A new way forward?
Will the future of addiction recovery take place on video conference screens and emailed notes? Even a few months ago, treating addiction patients remotely...
AbbVie has 47 reasons for its $2B cancer immunotherapy partnership with...
Another large drug company is getting into an emerging field of cancer immunotherapy with the announcement of a partnering deal with a Chinese company.
Chicago-based...
